An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
Interesting Engineering on MSN2h
US approves first nasal spray for major depressive disorder, PTSD conditionsJohnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...
In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.
The US Food and Drug Administration has approved a new nasal spray for depression treatment. Known as Spravato and ...
The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback